Stay updated with breaking news from Antitrust Improvements. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Phillips 66 signed an agreement to acquire Pinnacle Midland Parent for $550 million in cash as part of efforts to expand its midstream operations in the Pe...
The US competition regulator has launched an in-depth probe into Occidental's pending $12-billion acquisition of CrownRock.
/PRNewswire/ -- MediLink Therapeutics ("MediLink"), announced today that it has entered into a strategic research collaboration and worldwide license agreement...
On September 27, 2023, the United States District Court for the Eastern District of Louisiana concluded that the state action doctrine exempts a transaction between hospitals from the federal...
Coherus BioSciences to Receive $50 million Strategic Investment from Immuno-Oncology Partner Junshi Biosciences REDWOOD CITY, Calif., Feb. 02, 2021 (GLOBE NEWSWIRE) -- A day after announcing their new immuno-oncology collaboration, Coherus BioSciences, Inc. (Nasdaq: CHRS) (“Coherus”) announced that Shanghai Junshi Biosciences Co., Ltd (HK: 1877; SH: 688180) (“Junshi Biosciences”) intends to make a strategic investment of $50 million in Coherus pursuant to the terms of the definitive stock purchase agreement. “We view our collaboration with Coherus as a strategic long-term par...